Skip to main content
Equibles
QTRX logo

QTRX · Quanterix Corp · Metrics

Track QTRX — free

Use QTRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QTRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.15 +0.03 (+0.80%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$147.55M
Shares
47.29M
Volume · Oct 29 334.18K Avg daily vol (3M) 745.9K

QTRX metrics

81 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.15
Market cap
$147.55M

Price action

20 metrics
Price change (1W)
+11.8%
Price change (30D)
-15.0%
Price change (3M)
-7.7%
Price change (6M)
+2.3%
Price change (YTD)
-50.9%
Price change (1Y)
-43.1%
Trailing year
Price change (5Y)
-93.8%
52-week high
$8.06
52-week low
$2.42
Change from 52-week high
-61.3%
Change from 52-week low
+28.9%
Annualized volatility
92.1%
Annualized volatility (3M)
113.6%
Beta
2.0
RSI (14D)
52.9
Price vs SMA 50
+4.4%
Price vs SMA 200
-20.2%
Avg volume (3M)
747,428
Relative volume
0.9
Average dollar volume
$2.18M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
47.29M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 109.2%
P / book
0.6
reciprocal yield 168.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-87.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
10.8×
reciprocal yield 9.3%
EV / revenue historical average (5Y)
10.5×
reciprocal yield 9.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
44.6%
Operating margin
-99.6%
Trailing 12 months
Net margin
-80.2%
Gross profit (TTM)
$68.36M
Operating profit (TTM)
−$152.87M
Net income (TTM)
−$123.11M
Trailing 12 months
Diluted EPS (TTM)
$-2.62
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.28
Gross profit per diluted share (TTM)
$1.46
Operating profit per diluted share (TTM)
$-3.27
EBITDA per diluted share (TTM)
$-2.77
Net income per diluted share (TTM)
$-2.63
Operating cash flow per diluted share (TTM)
$-1.74
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.68
Stock compensation per diluted share (TTM)
$0.40
Book value per share
$6.33

Growth

11 metrics
Revenue growth YoY
+34.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$153.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.3%
Year over year · more shares
Revenue CAGR (3Y)
+9.6%
Revenue CAGR (5Y)
+10.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-51.9%
Return on assets
-38.5%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
−$129.47M
Free cash flow (TTM)
—
Quick ratio
2.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$44.17M
Total assets
$319.63M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$80.92M
Capital expenditures (TTM)
$762,000
R&D (TTM)
$31.95M
SG&A (TTM)
$133.61M
Stock compensation (TTM)
$18.62M
R&D / revenue
20.8%
Stock compensation / revenue
12.1%

Ownership (13F)

9 metrics
13F filers
133
13F filer change QoQ
+5
Institutional ownership
62.8%
Conviction holders (share of 13F filers)
1.5%
Crowding (high-turnover and private-fund holders)
30.8%
Private-fund adviser ownership
25.0%
Active holders' share change QoQ
-32.6%
Holder tenure
11.3
Price vs estimated holder cost
-29.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.5%

Short interest

3 metrics
Short interest
9.9%
Latest settlement · 8.4 days to cover
Days to cover
8.4d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
$286,354
Insider-sentiment score
85 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1503274 CUSIP 74766Q101 13F (30d) 18 filings 18 filers Visit website Investor relations